Mesh exposure after ventral hernia repair with onlay biosynthetic mesh: a retrospective review of associated risk factors and management strategies.

Publisher: Springer Country of Publication: France NLM ID: 9715168 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1248-9204 (Electronic) Linking ISSN: 12489204 NLM ISO Abbreviation: Hernia Subsets: MEDLINE

Original Publication: Paris, France : Springer, c1997-

Surgical Mesh*/adverse effects ; Hernia, Ventral*/surgery ; Herniorrhaphy*/adverse effects; Humans ; Middle Aged ; Female ; Retrospective Studies ; Male ; Risk Factors ; Aged ; Adult ; Recurrence ; Hydroxybutyrates ; Postoperative Complications/etiology ; Absorbable Implants/adverse effects ; Polyesters

Background: Although intraperitoneal and retromuscular mesh placement in ventral hernia repair (VHR) are associated with lower recurrence rates, the onlay plane remains a well-established option for certain clinical scenarios. A knowledge gap remains regarding resorbable biosynthetic onlay mesh and mesh exposure. We aim to determine exposure rate, risk factors, and treatment options.
Study Design: A single-center, two-surgeon retrospective review was performed examining patients who underwent VHR with onlay, Poly-4-hydroxybutyrate (P4HB) mesh from 2015 to 2021. Demographics, operative characteristics, outcomes, and mesh exposure management were analyzed.
Results: Of 346 patients, 15 (4.3%) experienced mesh exposure. The mean age was 53 years and BMI of 33.6 kg/m ² . Patients were majority ASA class 3 (65%), female (64.2%), and averaged a defect size of 307.9 ± 235.2 cm ² . Independent risk factors included diabetes (AOR = 4.3,CI 1.5-12.5;p < 0.005) and COPD (AOR = 5.2,CI 1.3-21.8;p = 0.02). Mesh exposures were identified as outpatient (20%) or intraoperative (80%). All underwent operative debridement, in which nine were managed with skin reclosure, two with partial closure, and four healed by secondary intention. Five patients required excision of unincorporated mesh. Four patients required further debridement from chronic surgical site occurrences; however, all mesh exposure patents healed after a mean of 260.8 ± 313.2 days and retained original mesh. The recurrence rate was 6.7% for mesh exposure patients.
Conclusion: When faced with mesh exposure, resorbable biosynthetic mesh placed in onlay fashion was retained in all patients. Patients with a history of diabetes or COPD have increased risk of mesh exposure and should be counseled.
(© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.)

Langbach O, Bukholm I, Benth J, Røkke O (2016) Long-term quality of life and functionality after ventral hernia mesh repair. Surg Endosc 30:5023–5033. https://doi.org/10.1007/s00464-016-4850-9. (PMID: 10.1007/s00464-016-4850-926969665)
Nissen AT, Henn D, Moshrefi S, Gupta D, Nazerali R, Lee GK (2019) Health-Related Quality of Life after ventral hernia repair with Biologic and Synthetic Mesh. Ann Plast Surg 82:S332–s8. https://doi.org/10.1097/sap.0000000000001768. (PMID: 10.1097/sap.000000000000176830633027)
van Ramshorst GH, Eker HH, Hop WC, Jeekel J, Lange JF (2012) Impact of incisional hernia on health-related quality of life and body image: a prospective cohort study. Am J Surg 204:144–150. https://doi.org/10.1016/j.amjsurg.2012.01.012. (PMID: 10.1016/j.amjsurg.2012.01.01222579232)
Poulose BK, Shelton J, Phillips S, Moore D, Nealon W, Penson D et al (2012) Epidemiology and cost of ventral hernia repair: making the case for hernia research. Hernia 16:179–183. https://doi.org/10.1007/s10029-011-0879-9. (PMID: 10.1007/s10029-011-0879-921904861)
Kadakia N, Mudgway R, Vo J, Vong V, Seto T, Bortz P, Depew A (2020) Long-term outcomes of ventral hernia repair: an 11-Year Follow-Up. Cureus 12:e9523. https://doi.org/10.7759/cureus.9523. (PMID: 10.7759/cureus.9523329051507466072)
Luijendijk RW, Hop WCJ, van den Tol MP, de Lange DCD, Braaksma MMJ, IJzermans JNM et al (2000) A comparison of suture repair with Mesh Repair for Incisional Hernia. N Engl J Med 343:392–398. https://doi.org/10.1056/nejm200008103430603. (PMID: 10.1056/nejm20000810343060310933738)
Burger JWA, Luijendijk RW, Hop WCJ, Halm JA, Verdaasdonk EGG, Jeekel J (2004) Long-term follow-up of a Randomized Controlled Trial of Suture Versus Mesh Repair of Incisional Hernia. Ann Surg 240:578–585. https://doi.org/10.1097/01.sla.0000141193.08524.e7. (PMID: 10.1097/01.sla.0000141193.08524.e7153837851356459)
Breuing K, Butler CE, Ferzoco S, Franz M, Hultman CS, Kilbridge JF et al (2010) Incisional ventral hernias: review of the literature and recommendations regarding the grading and technique of repair. Surgery 148:544–558. https://doi.org/10.1016/j.surg.2010.01.008. (PMID: 10.1016/j.surg.2010.01.00820304452)
Nguyen MT, Berger RL, Hicks SC, Davila JA, Li LT, Kao LS, Liang MK (2014) Comparison of outcomes of synthetic mesh vs suture repair of Elective primary ventral herniorrhaphy. JAMA Surg 149:415–421. (PMID: 10.1001/jamasurg.2013.501424554114)
Rastegarpour A, Cheung M, Vardhan M, Ibrahim MM, Butler CE, Levinson H (2016) Surgical mesh for ventral incisional hernia repairs: understanding mesh design. Plast Surg (Oakv) 24:41–50. https://doi.org/10.4172/plastic-surgery.1000955. (PMID: 10.4172/plastic-surgery.100095527054138)
Christopher AN, Patel V, Othman S, Jia H, Mellia JA, Broach RB, Fischer JP (2021) Onlay Poly-4-Hydroxybutyrate (P4HB) mesh for Complex Hernia: early clinical and patient reported outcomes. J Surg Res 264:199–207. https://doi.org/10.1016/j.jss.2021.02.012. (PMID: 10.1016/j.jss.2021.02.01233838404)
Mellia JA, Othman S, Naga HI, Messa CAI, Elfanagely O, Byrnes YM et al (2020) Outcomes of Poly-4-hydroxybutyrate mesh in ventral hernia repair: a systematic review and pooled analysis. Plast Reconstr Surg – Global Open 8:e3158. https://doi.org/10.1097/gox.0000000000003158. (PMID: 10.1097/gox.0000000000003158)
Totten CF, Davenport DL, Ward ND, Roth JS (2016) Cost of ventral hernia repair using biologic or synthetic mesh. J Surg Res 203. http://doi.org/https://doi.org/ https://doi.org/10.1016/j.jss.2016.02.040 . :459 – 65.
Huntington CR, Cox TC, Blair LJ, Schell S, Randolph D, Prasad T et al (2016) Biologic mesh in ventral hernia repair: outcomes, recurrence, and charge analysis. Surgery 160:1517–1527. https://doi.org/10.1016/j.surg.2016.07.008. (PMID: 10.1016/j.surg.2016.07.00827528210)
Talwar AA, Perry NJ, McAuliffe PB, Desai AA, Thrippleton S, Broach RB, Fischer JP (2022) Shifting the Goalpost in ventral hernia care: 5-year outcomes after ventral hernia repair with poly-4-hydroxybutyrate mesh. Hernia 26:1635–1643. https://doi.org/10.1007/s10029-022-02674-y. (PMID: 10.1007/s10029-022-02674-y36114396)
Williams SF, Martin DP, Moses AC (2016) The history of GalaFLEX P4HB Scaffold. Aesthetic Surg J 36:S33–S42. https://doi.org/10.1093/asj/sjw141. (PMID: 10.1093/asj/sjw141)
Plymale MA, Davenport DL, Dugan A, Zachem A, Roth JS (2018) Ventral hernia repair with poly-4-hydroxybutyrate mesh. Surg Endosc 32:1689–1694. https://doi.org/10.1007/s00464-017-5848-7. (PMID: 10.1007/s00464-017-5848-728916979)
Christopher AN, Morris MP, Patel V, Mellia JA, Fowler C, Messa CA et al (2021) An evaluation of clinical and quality of life outcomes after ventral hernia repair with poly-4-hydroxybutyrate mesh. Hernia 25:717–726. https://doi.org/10.1007/s10029-021-02394-9. (PMID: 10.1007/s10029-021-02394-933907919)
Buell JF, Sigmon D, Ducoin C, Shapiro M, Teja N, Wynter E et al (2017) Initial experience with Biologic Polymer Scaffold (Poly-4-hydroxybuturate) in Complex Abdominal Wall Reconstruction. Ann Surg 266:185–188. https://doi.org/10.1097/sla.0000000000001916. (PMID: 10.1097/sla.000000000000191628594679)
Deeken CR, Matthews BD (2013) Characterization of the mechanical strength, Resorption Properties, and histologic characteristics of a fully absorbable material (Poly-4-hydroxybutyrate—PHASIX mesh) in a Porcine Model of Hernia Repair. ISRN Surg 2013(238067). https://doi.org/10.1155/2013/238067.
Levy AS, Bernstein JL, Premaratne ID, Rohde CH, Otterburn DM, Morrison KA et al (2021) Poly-4-hydroxybutyrate (Phasix™) mesh onlay in complex abdominal wall repair. Surg Endosc 35:2049–2058. https://doi.org/10.1007/s00464-020-07601-9. (PMID: 10.1007/s00464-020-07601-932385706)
Roth JS, Anthone GJ, Selzer DJ, Poulose BK, Pierce RA, Bittner JG et al (2021) Prospective, multicenter study of P4HB (Phasix™) mesh for hernia repair in cohort at risk for complications: 3-Year follow-up. Annals Med Surg 61:1–7. https://doi.org/10.1016/j.amsu.2020.12.002. (PMID: 10.1016/j.amsu.2020.12.002)
Layer T, Benammi S, Dubuisson V, Manfredelli S, Passot G, Charleux-Muller D et al (2023) Incisional hernia repair with a slowly absorbable P4HB mesh: what happens after the mesh disappears? A retrospective longitudinal clinical study. Hernia 27:387–394. https://doi.org/10.1007/s10029-022-02616-8. (PMID: 10.1007/s10029-022-02616-835536373)
Christopher AN, Morris MP, Jia H, Broach R, Fischer JP (2021) Resorbable synthetic ventral hernia repair in contaminated fields: outcomes with poly-4-Hydroxybutyrate mesh. Plast Reconstr Surg 148:1367–1375. https://doi.org/10.1097/prs.0000000000008579. (PMID: 10.1097/prs.000000000000857934757999)
Messa CAt, Amro C, Niu EF, Habarth-Morales TE, Talwar AA, Thrippleton S et al (2023) Transversus abdominis release with biosynthetic mesh for large ventral hernia repair: a 5-year analysis of clinical outcomes and quality of life. https://doi.org/10.1007/s10029-023-02889-7 . Hernia.
Sosin M, Nahabedian MY, Bhanot P (2018) The Perfect plane: a systematic review of Mesh Location and outcomes, Update 2018. Plast Reconstr Surg 142:107S–16S. https://doi.org/10.1097/prs.0000000000004864. (PMID: 10.1097/prs.000000000000486430138278)
Kokotovic D, Gögenur I, Helgstrand F (2017) Substantial variation among hernia experts in the decision for treatment of patients with incisional hernia: a descriptive study on agreement. Hernia 21:271–278. https://doi.org/10.1007/s10029-016-1562-y. (PMID: 10.1007/s10029-016-1562-y27915385)
Holihan JL, Nguyen DH, Nguyen MT, Mo J, Kao LS, Liang MK (2016) Mesh location in Open ventral hernia repair: a systematic review and network Meta-analysis. World J Surg 40:89–99. https://doi.org/10.1007/s00268-015-3252-9. (PMID: 10.1007/s00268-015-3252-926423675)
Haskins IN, Voeller GR, Stoikes NF, Webb DL, Chandler RG, Phillips S et al (2017) Onlay with Adhesive Use compared with Sublay Mesh Placement in ventral hernia repair: was Chevrel Right? An Americas Hernia Society Quality Collaborative Analysis. J Am Coll Surg 224:962–970. https://doi.org/10.1016/j.jamcollsurg.2017.01.048. (PMID: 10.1016/j.jamcollsurg.2017.01.04828161483)
Cano-Valderrama O, Porrero JL, Quirós E, Bonachia O, Castillo MJ, Cervantes N et al (2019) Is Onlay Polypropylene Mesh Repair an available option for Incisional Hernia Repair? A retrospective cohort study. Am Surg 85:183–187. (PMID: 10.1177/00031348190850022630819296)
Ahmad S, Mufti TS, Zafar A, Akbar I (2007) Conservative management of mesh site infection in ventral hernia repair. J Ayub Med Coll Abbottabad 19:75–77. (PMID: 18693604)
Trunzo JA, Ponsky JL, Jin J, Williams CP, Rosen MJ (2009) A novel approach for salvaging infected prosthetic mesh after ventral hernia repair. Hernia 13:545–549. https://doi.org/10.1007/s10029-009-0470-9. (PMID: 10.1007/s10029-009-0470-919214650)
Sadava EE, Bras Harriott C, Angeramo CA, Schlottmann F (2022) Synthetic mesh in contaminated abdominal wall surgery: friend or foe? A literature review. J Gastrointest Surg 26:235–244. https://doi.org/10.1007/s11605-021-05155-2. (PMID: 10.1007/s11605-021-05155-234590215)
Greenberg JJ (2010) Can infected composite mesh be salvaged? Hernia 14:589 – 92. https://doi.org/10.1007/s10029-010-0694-8.
Kao AM, Arnold MR, Augenstein VA, Heniford BT (2018) Prevention and Treatment Strategies for Mesh Infection in Abdominal Wall Reconstruction. Plast Reconstr Surg 142:149s-55s. https://doi.org/10.1097/prs.0000000000004871.
Ahmed M, Mehboob M (2019) Comparisons of Onlay versus Sublay Mesh fixation technique in ventral Abdominal Wall Incisional Hernia Repair. J Coll Physicians Surg Pak 29:819–822. https://doi.org/10.29271/jcpsp.2019.09.819. (PMID: 10.29271/jcpsp.2019.09.81931455474)
Bueno-Lledó J, Torregrosa-Gallud A, Sala-Hernandez A, Carbonell-Tatay F, Pastor PG, Diana SB, Hernández JI (2017) Predictors of mesh infection and explantation after abdominal wall hernia repair. Am J Surg 213:50–57. https://doi.org/10.1016/j.amjsurg.2016.03.007. (PMID: 10.1016/j.amjsurg.2016.03.00727421189)
Shubinets V, Carney MJ, Colen DL, Mirzabeigi MN, Weissler JM, Lanni MA et al (2018) Management of infected Mesh after Abdominal Hernia Repair: systematic review and single-Institution experience. Ann Plast Surg 80:145–153. https://doi.org/10.1097/sap.0000000000001189. (PMID: 10.1097/sap.000000000000118928671890)
van Rooijen MMJ, Jairam AP, Tollens T, Jørgensen LN, de Vries Reilingh TS, Piessen G et al (2018) A post-market, prospective, multi-center, single-arm clinical investigation of Phasix™ mesh for VHWG grade 3 midline incisional hernia repair: a research protocol. BMC Surg 18:104. https://doi.org/10.1186/s12893-018-0439-7. (PMID: 10.1186/s12893-018-0439-7304587476247668)
Vauclair E, Bert M, Facy O, Cheynel N, Rat P, Ortega-Deballon P (2021) What results can be expected one year after complex incisional hernia repair with biosynthetic mesh? J Visc Surg 158:111–117. https://doi.org/10.1016/j.jviscsurg.2020.07.008. (PMID: 10.1016/j.jviscsurg.2020.07.00833454303)
Roth JS, Anthone GJ, Selzer DJ, Poulose BK, Bittner JG, Hope WW et al (2018) Prospective evaluation of poly-4-hydroxybutyrate mesh in CDC class I/high-risk ventral and incisional hernia repair: 18-month follow-up. Surg Endosc 32:1929–1936. https://doi.org/10.1007/s00464-017-5886-1. (PMID: 10.1007/s00464-017-5886-129063307)
Charleux-Muller D, Romain B, Boisson C, Velten M, Brigand C, Lejeune C (2022) Cost-effectiveness analysis of resorbable biosynthetic mesh in contaminated ventral hernia repair. J Visc Surg 159:279–285. https://doi.org/10.1016/j.jviscsurg.2021.06.001. (PMID: 10.1016/j.jviscsurg.2021.06.00134116953)
Messa CAt, Kozak G, Broach RB, Fischer JP (2019) When the Mesh goes away: an analysis of Poly-4-Hydroxybutyrate Mesh for Complex Hernia Repair. Plast Reconstr Surg Glob Open 7:e2576. https://doi.org/10.1097/gox.0000000000002576. (PMID: 10.1097/gox.0000000000002576)
Huntington C, Gamble J, Blair L, Cox T, Prasad T, Lincourt A et al (2016) Quantification of the Effect of Diabetes Mellitus on ventral hernia repair: results from two National registries. Am Surg 82:661–671. (PMID: 10.1177/00031348160820082227657579)
Ferguson DH, Smith CG, Olufajo OA, Zeineddin A, Williams M (2021) Risk factors Associated with adverse outcomes after ventral hernia repair with component separation. J Surg Res 258:299–306. https://doi.org/10.1016/j.jss.2020.08.063. (PMID: 10.1016/j.jss.2020.08.06333039639)
Fischer JP, Wink JD, Nelson JA, Kovach SJ 3rd (2014) Among 1,706 cases of abdominal wall reconstruction, what factors influence the occurrence of major operative complications? Surgery 155:311–319. https://doi.org/10.1016/j.surg.2013.08.014. (PMID: 10.1016/j.surg.2013.08.01424433774)
Quiroga-Centeno AC, Quiroga-Centeno CA, Guerrero-Macías S, Navas-Quintero O, Gómez-Ochoa SA (2022) Systematic review and meta-analysis of risk factors for mesh infection following Abdominal Wall Hernia repair surgery. Am J Surg 224:239–246. https://doi.org/10.1016/j.amjsurg.2021.12.024. (PMID: 10.1016/j.amjsurg.2021.12.02434969506)
Chang F-Y, Shaio M-F (1995) Respiratory burst activity of monocytes from patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 29:121–127. https://doi.org/10.1016/0168-8227(95)01123-4. (PMID: 10.1016/0168-8227(95)01123-48591699)
Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B (1997) Impaired leucocyte functions in diabetic patients. Diabet Med 14:29–34. https://doi.org/10.1002/(sici)1096-9136(199701)14:1%3C29::Aid-dia300%3E3.0.Co;2-v. (PMID: 10.1002/(sici)1096-9136(199701)14:1<29::Aid-dia300>3.0.Co;2-v9017350)
Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W (1997) Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies and Basic Foundation. Annals of Plastic Surgery 38.
Garcia-Ruano A, Deleyto E, Garcia-Fernandez S (2016) VAC-instillation therapy in abdominal mesh exposure: a novel indication. J Surg Res 206:292–297. https://doi.org/10.1016/j.jss.2016.08.030. (PMID: 10.1016/j.jss.2016.08.03027884322)
Schlosser KA, Warren JA (2023) Hernia mesh complications: management of Mesh infections and Enteroprosthetic Fistula. Surg Clin North Am 103:1029–1042. https://doi.org/10.1016/j.suc.2023.04.011. (PMID: 10.1016/j.suc.2023.04.01137709388)
Bueno-Lledó J, Martinez-Hoed J, Bonafe-Diana S, Pous-Serrano S (2023) Mesh infection after Hernia Repair and negative pressure wound therapy. A systematic review. World J Surg 47:1495–1502. https://doi.org/10.1007/s00268-023-06943-4. (PMID: 10.1007/s00268-023-06943-436802233)
Chung L, Tse GH, O’Dwyer PJ (2014) Outcome of patients with chronic mesh infection following abdominal wall hernia repair. Hernia 18:701–704. https://doi.org/10.1007/s10029-014-1277-x. (PMID: 10.1007/s10029-014-1277-x25038894)
Kao AM, Arnold MR, Otero J, Huang L-C, Prasad T, Lincourt AE, Augenstein VA (2020) Comparison of outcomes after partial Versus Complete Mesh Excision. Annals of Surgery 272.
Sabbagh C, Verhaeghe P, Brehant O, Browet F, Garriot B, Regimbeau JM (2012) Partial removal of infected parietal meshes is a safe procedure. Hernia 16:445–449. https://doi.org/10.1007/s10029-012-0931-4. (PMID: 10.1007/s10029-012-0931-422689250)
Rath A, Zhang J, Chevrel JP (1997) The sheath of the rectus abdominis muscle: an anatomical and biomechanical study. Hernia 1:139–142. (PMID: 10.1007/BF02426420)
Amid PK, Shulman AG, Lichtenstein IL, Hakakha M (1994) Biomaterials for abdominal wall hernia surgery and principles of their applications. Langenbecks Arch Chir 379:168–171. https://doi.org/10.1007/bf00680113. (PMID: 10.1007/bf006801138052058)
Klinge U, Junge K, Spellerberg B, Piroth C, Klosterhalfen B, Schumpelick V (2002) Do multifilament alloplastic meshes increase the infection rate? Analysis of the polymeric surface, the bacteria adherence, and the in vivo consequences in a rat model. J Biomed Mater Res 63:765–771. https://doi.org/10.1002/jbm.10449. (PMID: 10.1002/jbm.1044912418022)
Kummerow Broman K, Huang L-C, Faqih A, Phillips SE, Baucom RB, Pierce RA et al (2017) Hidden morbidity of ventral hernia repair with mesh: as concerning as common bile Duct Injury? J Am Coll Surg 224:35–42. https://doi.org/10.1016/j.jamcollsurg.2016.09.016. (PMID: 10.1016/j.jamcollsurg.2016.09.01627725219)
Majumder A, Winder JS, Wen Y, Pauli EM, Belyansky I, Novitsky YW (2016) Comparative analysis of biologic versus synthetic mesh outcomes in contaminated hernia repairs. Surgery 160:828–838. https://doi.org/10.1016/j.surg.2016.04.041. (PMID: 10.1016/j.surg.2016.04.04127452954)
Plymale MA, Davenport DL, Walsh-Blackmore S, Hess J, Griffiths WS, Plymale MC et al (2019) Costs and complications Associated with infected mesh for ventral hernia repair. Surg Infect 21:344–349. https://doi.org/10.1089/sur.2019.183. (PMID: 10.1089/sur.2019.183)

Keywords: Biosynthetic mesh; Mesh exposure; Mesh exposure management; Onlay mesh; Ventral hernia repair

0 (poly(4-hydroxybutanoate))
0 (Hydroxybutyrates)
0 (Polyesters)

Date Created: 20240920 Date Completed: 20241101 Latest Revision: 20241121

20241121

10.1007/s10029-024-03108-7

39304545